newsfilter
← Latest News
GlobeNewswire·

Kyverna Therapeutics to Participate in Upcoming March Investor Conferences

EMERYVILLE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today